These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18997036)

  • 1. 18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas.
    Fassan M; Pizzi S; Sperti C; Pasquali C; Pedrazzoli S; Chierichetti F; Parenti AR
    J Nucl Med; 2008 Dec; 49(12):2070. PubMed ID: 18997036
    [No Abstract]   [Full Text] [Related]  

  • 2. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
    Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
    Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 fluorodeoxyglucose uptake in a solid pseudopapillary tumor of the pancreas mimicking malignancy.
    Shimada K; Nakamoto Y; Isoda H; Maetani Y; Yamashita R; Arizono S; Hirokawa Y; Nitta T; Doi R; Haga H; Togashi K
    Clin Nucl Med; 2008 Nov; 33(11):766-8. PubMed ID: 18936608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
    Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients.
    Kaida H; Azuma K; Kawahara A; Yasunaga M; Kitasato Y; Hattori S; Taira T; Ureshino H; Kage M; Ishii K; Murakami T; Ishibashi M
    Eur J Radiol; 2016 Oct; 85(10):1804-1810. PubMed ID: 27666620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer.
    Takahashi M; Nojima H; Kuboki S; Horikoshi T; Yokota T; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
    Pancreatology; 2020 Sep; 20(6):1205-1212. PubMed ID: 32819845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
    Reske SN; Grillenberger KG; Glatting G; Port M; Hildebrandt M; Gansauge F; Beger HG
    J Nucl Med; 1997 Sep; 38(9):1344-8. PubMed ID: 9293784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
    Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma?
    Kang CM; Cho A; Kim H; Chung YE; Hwang HK; Choi SH; Lee WJ
    Pancreatology; 2014; 14(6):515-23. PubMed ID: 25256437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal Papillary Mucinous Neoplasm of the Pancreas With High Malignant Potential on FDG PET/MRI.
    Huo L; Feng F; Liao Q; Jin Z; Li F; Zhao Y
    Clin Nucl Med; 2016 Dec; 41(12):989-990. PubMed ID: 27764041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
    Chong JU; Hwang HK; Lee JH; Yun M; Kang CM; Lee WJ
    PLoS One; 2017; 12(2):e0172606. PubMed ID: 28235029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT.
    Toshikuni N; Kai K; Fujisawa M
    Ann Nucl Med; 2008 Feb; 22(2):133-7. PubMed ID: 18311538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.
    von Forstner C; Egberts JH; Ammerpohl O; Niedzielska D; Buchert R; Mikecz P; Schumacher U; Peldschus K; Adam G; Pilarsky C; Grutzmann R; Kalthoff H; Henze E; Brenner W
    J Nucl Med; 2008 Aug; 49(8):1362-70. PubMed ID: 18632830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
    Nguyen XC; So Y; Chung JH; Lee WW; Park SY; Kim SE
    Eur J Cancer; 2008 Mar; 44(5):692-8. PubMed ID: 18314327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.